Skip to the page

Data / Drug companies / Bell Pharmaceuticals, Inc.

Bell Pharmaceuticals, Inc.: 7 products in the FDA NDC directory, labeler code 15579

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Bell Pharmaceuticals, Inc. (labeler code 15579) lists 7 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 6 over the counter drugs, 1 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 1, 2023.

The request: Watch Bell Pharmaceuticals, Inc. (FDA labeler code 15579): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
15579
Products in commercial distribution
7
Packages
9
Finished drugs by generic name
5
Prescription products
0
Over the counter products
6
Flagged as original packager
3 of 3 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
November 26, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs571.4%
Drugs for further processing114.3%
Unapproved homeopathic products114.3%

Products by type

TypeProductsShare
Over the counter drugs685.7%
Drugs for further processing114.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Solution/ drops342.9%
Tablet, coated228.6%
Tablet114.3%
Kit114.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Carbamide peroxide15579-840Solution/ dropsDrugs for further processingMarch 1, 2023
Otix Ear wax Removal System Ear wax and Bulb15579-839KitOver the counter monograph drugsOctober 1, 2021
Otix Ear wax Removal Drops15579-838Solution/ dropsOver the counter monograph drugsOctober 1, 2021
Otix Ear Relief Ear Drops15579-105Solution/ dropsUnapproved homeopathic productsAugust 16, 2021
Jet-Asleep Double Strength Night Time Sleep Aid15579-828TabletOver the counter monograph drugsOctober 7, 2017
JET ALERT Regular Strength15579-201Tablet, coatedOver the counter monograph drugsJuly 27, 2016
JET ALERT Double Strength15579-200Tablet, coatedOver the counter monograph drugsNovember 26, 2014

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.